The global mitochondrial-based therapeutics market is set to witness robust growth, projected to reach USD 854.2 million by 2033, expanding at a rapid CAGR of 7.8% from 2023 onwards. This estimation, initially valued at USD 403.06 million in 2023, underscores a promising trajectory driven by increasing incidences of mitochondrial diseases and advancements in therapeutic interventions. …